Perspective Therapeutics annual debt-to-assets ratio
2020
2021
2022
2022
2023
2024
2025
Perspective Therapeutics Debt-to-Assets Ratio Growth & History (CATX)
Perspective Therapeutics's debt-to-assets ratio was 0.01 for fiscal 2025.
View full Perspective Therapeutics company overviewPerspective Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.01 | 0.00 | +2.32% |
| 2024 | 2024-12-31 | 0.01 | −0.01 | −54.30% |
| 2023 | 2023-12-31 | 0.03 | 0.02 | +286.18% |
| 2022 · Dec 31 | 2022-12-31 | 0.01 | — | — |
| 2022 · Jun 30 | 2022-06-30 | 0.01 | −0.00 | −26.21% |
| 2021 | 2021-06-30 | 0.01 | −0.10 | −90.46% |
| 2020 | 2020-06-30 | 0.12 | — | — |
Perspective Therapeutics quarterly debt-to-assets ratio
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.01 | −0.00 | −11.99% |
| Q1 2026 | 2026-03-31 | 0.01 | −0.00 | −11.15% |
| Q4 2025 | 2025-12-31 | 0.01 | 0.00 | +2.32% |
| Q3 2025 | 2025-09-30 | 0.01 | 0.00 | +2.99% |
| Q2 2025 | 2025-06-30 | 0.01 | 0.00 | +14.39% |
| Q1 2025 | 2025-03-31 | 0.01 | 0.00 | +12.09% |
| Q4 2024 | 2024-12-31 | 0.01 | −0.01 | −54.30% |
| Q3 2024 | 2024-09-30 | 0.01 | −0.02 | −63.52% |
| Q2 2024 | 2024-06-30 | 0.01 | −0.01 | −53.19% |
| Q1 2024 | 2024-03-31 | 0.01 | −0.01 | −37.64% |
| Q4 2023 | 2023-12-31 | 0.03 | 0.02 | +286.18% |
| Q3 2023 | 2023-09-30 | 0.03 | 0.02 | +308.46% |
| Q2 2023 | 2023-06-30 | 0.02 | 0.01 | +163.77% |
| Q1 2023 · Mar 31 | 2023-03-31 | 0.02 | 0.01 | +86.48% |
| Q4 2022 · Dec 31 | 2022-12-31 | 0.01 | −0.00 | −30.40% |
| Q1 2023 · Sep 30 | 2022-09-30 | 0.01 | −0.00 | −29.62% |
| Q4 2022 · Jun 30 | 2022-06-30 | 0.01 | −0.00 | −26.21% |
| Q3 2022 | 2022-03-31 | 0.01 | −0.00 | −24.35% |
| Q2 2022 | 2021-12-31 | 0.01 | −0.05 | −83.23% |
| Q1 2022 | 2021-09-30 | 0.01 | −0.11 | −91.26% |
| Q4 2021 | 2021-06-30 | 0.01 | −0.10 | −90.46% |
| Q3 2021 | 2021-03-31 | 0.01 | −0.11 | −90.08% |
| Q2 2021 | 2020-12-31 | 0.06 | −0.07 | −53.80% |
| Q1 2021 | 2020-09-30 | 0.12 | 0.00 | +2.82% |
| Q4 2020 | 2020-06-30 | 0.12 | — | — |
| Q3 2020 | 2020-03-31 | 0.12 | — | — |
| Q2 2020 | 2019-12-31 | 0.13 | — | — |
| Q1 2020 | 2019-09-30 | 0.12 | — | — |
Perspective Therapeutics debt-to-assets ratio trends
Between the periods ended 2020-06-30 and 2025-12-31, Perspective Therapeutics's debt-to-assets ratio decreased from 0.12 to 0.01, a change of −0.10. The latest reported quarter, Q2 2026, shows 0.01.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Perspective Therapeutics source filings ↗